Lesion Size Determines Accuracy of Thallium-201 Brain Single-Photon Emission Tomography in Differentiating between Intracranial Malignancy and Infection in AIDS Patients

References

1. ↵
   Rosenblum ML, Levy RM, Bredesen DR. Neurosurgical implications of the acquired immunodeficiency syndrome (AIDS). Clin Neurosurg 1988;34:419–445

   PubMed
2. ↵
   Cohn JA, McMeeking A, Cohen W, et al. Evaluation of the policy of empiric treatment of suspected toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Am J Med 1989;86:521–527

   CrossRefPubMedWeb of Science
3. ↵
   Luft BJ, Hafner R, Korzun AH, et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1993;329:995–1000

   CrossRefPubMedWeb of Science
4. ↵
   Iglesias-Rozas JR, Bantz B, Adler T, et al. Cerebral lymphoma in AIDS: clinical, radiological, neuropathological and immunopathological study. Clin Neuropathol 1991;10:65–72

   PubMed
5. ↵
   Chiang FL, Miller BL, Chang L, et al. Fulminant cerebral lymphoma in AIDS. AJNR Am J Neuroradiol 1996;17:157–160

   Abstract
6. ↵
   Baumgartner JE, Rachlin JR, Beckstead JH, et al. Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 1990;73:206–211

   CrossRefPubMedWeb of Science
7. ↵
   Ghesani M, Viswamitra S, Kagetsu NL, et al. Lesion size is an important determinant of the accuracy of TL-201 brain SPECT in the evaluation of intracranial lesions in AIDS patients [Abstract]. J Nucl Med 1999;40:199P
8. ↵
   O’Malley JP, Ziessman HA, Kumar PN, et al. Diagnosis of intracranial lymphoma in patients with AIDS: value of P^201P Tl single-photon emission computed tomography. AJR Am J Roentgenol 1994;163:417–421

   PubMedWeb of Science
9. ↵
   Miller RF, Hall-Craggs MA, Costa DC, et al. Magnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS. Sex Transm Infect 1998;74:258–264

   Abstract
10. ↵
    Ruiz A, Ganz WI, Post MJD, et al. Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from toxoplasma encephalitis in AIDS patients. AJNR Am J Neuroradiol 1994;15:1885–1894

    Abstract/FREE Full Text
11. ↵
    Chang L, Cornford ME, Chiang FL. Radiologic-pathologic correlation: cerebral toxoplasmosis and lymphoma in AIDS. AJNR Am J Neuroradiol 1995;16:1653–1663

    PubMed
12. ↵
    Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993;3:255–268

    CrossRefPubMedWeb of Science
13. ↵
    Krishna L, Slizofski WJ, Katsetos CD, et al. Abnormal intracerebral thallium localization in a bacterial brain abscess. J Nucl Med 1992;33:2017–2019

    Abstract/FREE Full Text
14. ↵
    Gorniak RJT, Kramer EL, McMeeking AA, et al. Thallium-201 uptake in cytomegalovirus encephalitis. J Nucl Med 1997;38:1386–1388

    Abstract/FREE Full Text
15. ↵
    Fisher DC, Chason DP, Mathews D, et al. Central nervous system lymphoma not detectable on single-photon emission CT with thallium 201. AJNR Am J Neuroradiol 1996;17:1687–1690

    Abstract
16. ↵
    Campbell BG, Hurley J, Zimmerman RD. False-negative single-photon emission CT in AIDS lymphoma: lack of effect of steroids. AJNR Am J Neuroradiol 1996;17:1000–1002

    PubMedWeb of Science
17. ↵
    Berry I, Gaillard JF, Guo Z, et al. Cerebral lesion in AIDS: what can be expected from scintigraphy? Cerebral tomographic scintigraphy using thallium-201: a contribution to the differential diagnosis of lymphomas and infectious lesions. J Neuroradiol 1995;22:218–228

    PubMed
18. ↵
    Lorberboym M, Estok L, Machac J, et al. Rapid differential diagnosis of cerebral toxoplasmosis and primary central nervous system lymphoma by thallium-201 SPECT. J Nucl Med 1996;37:1150–1154

    Abstract/FREE Full Text
19. ↵
    Kim KT, Black KL, Marciano D, et al. Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 1990;31:965–969

    Abstract/FREE Full Text
20. D’Amico A, Mesa C, Castagna A, et al. Diagnostic accuracy and predictive value of 201Tl SPET for the differential diagnosis of cerebral lesions in AIDS patients. Nucl Med Commun 1997;18:741–750

    CrossRefPubMedWeb of Science
21. ↵
    Black KL, Hawkins RA, Kim KT, et al. Use of thallium-201 SPECT to quantitate malignancy of gliomas. J Neurosurg 1989;71:342–346

    PubMedWeb of Science
22. ↵
    Kessler LS, Ruiz A, Post MJD, et al. Thallium-201 brain SPECT of lymphoma in AIDS patients: pitfalls and technique optimization. AJNR Am J Neuroradiol 1998;19:1105–1109

    Abstract
23. ↵
    Skiest DJ, Erdman W, Chang WE, et al. SPECT thallium-201 combined with toxoplasma serology for the presumptive diagnosis of focal central nervous system mass lesions in patients with AIDS. J Infect 2000;40:274–281

    CrossRefPubMedWeb of Science
24. ↵
    Heald AE, Hoffman JM, Bartlett JA, Waskin HA. Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET). Int J STD AIDS 1996;7:337–346

    Abstract/FREE Full Text
25. Pierce MA, Johnson MD, Maciunas RJ, et al. Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann Int Med 1995;123:594–598

    PubMedWeb of Science
26. ↵
    Hoffman JM, Waskin HA, Schifter T, et al. FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med 1993;34:567–575

    Abstract/FREE Full Text
27. ↵
    Pomper MG, Constantinides CD, Barker PB, et al. Quantitative MR spectroscopic imaging of brain lesions in patients with AIDS: correlation with [11C-methyl]thymidine PET and thallium-201 SPECT. Acta Radiol 2002;9:396–409
28. ↵
    Chinn RJS, Wilkinson ID, Hall-Craggs MA, et al. Toxoplasmosis and primary central nervous system lymphoma in HIV infection: diagnosis with MR spectroscopy. Radiology 1995;197:649–654

    PubMedWeb of Science
29. ↵
    Kaplan WD, Takvorian T, Morris JH, et al. Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 1987;28:47–52
30. ↵
    Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1993;23:1643–1648
31. ↵
    Antinori A, Ammassari A, De Luca A, et al. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology 1997;48:687–694

    Abstract/FREE Full Text
32. ↵
    Castagna A, Cinque P, D’Amico A, et al. Evaluation of contrast-enhancing brain lesions in AIDS patients by means of Epstein-Barr virus detection in cerebrospinal fluid and 201-thallium single photon emission tomography. AIDS 1997;11:1522–1523

    PubMedWeb of Science
33. ↵
    Skolasky RL, Dal Pan GJ, Olivi A, et al. HIV-associated primary CNS morbidity and utility of brain biopsy. J Neurol Sci 1999;163:32–38

    CrossRefPubMedWeb of Science
34. ↵
    Chappell ET, Guthrie BL, Orenstein J. The role of stereotactic biopsy in the management of HIV-related focal brain lesions. Neurosurg 1992;30:825–829